Joel Stern, Jeffrey McCracken Discuss ‘Megamergers’ (Audio)

Joel Stern, chief executive officer at Stern Value Management, and Jeffrey McCracken, managing editor of global deals for Bloomberg News, discuss Pfizer Inc. (PFE)’s proposal to buy AstraZeneca Plc (AZN) for about 58.8 billion pounds ($98.7 billion) in what would rank as the industry’s biggest-ever takeover. Stern and McCracken talk with Bloomberg’s Pimm Fox and Carol Massar on Bloomberg Radio’s "Taking Stock" on April 28th.

Running time 10:54

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.